Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hildegard Poppe"'
Autor:
Degenhard Marx, Natalia V. Kaverina, Sergey F. Sokolov, Reni Dr. Bartsch, Arkadi M. Lichoscherstow, Sergey Borisenko, Wolfgang Sauer, Hildegard Poppe, Valentin V. Lyskovtsev, Rudolf Schindler, Sergey B. Seredenin
Publikováno v:
Archiv der Pharmazie. 332:233-242
In the search for new anti-arrhythmic substances we discovered the class III activity of aminocarboxamides. These compounds show a prolongation of the effective refractory period. With some of them the prolongation is more pronounced after faster tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7fea5841e0926809db4c1bcbaeb1932
https://doi.org/10.1002/(sici)1521-4184(19997)332:7<233::aid-ardp233>3.0.co
https://doi.org/10.1002/(sici)1521-4184(19997)332:7<233::aid-ardp233>3.0.co
Autor:
Ute Egerland, Ilona Dr Fleischhauer, Hildegard Poppe, Szelenyi I, Jürgen Engel, Rudolf Schindler, Norbert Höfgen, Wolfgang Sauer, Sabine Heer, Bernhard Kutscher
Publikováno v:
Archiv der Pharmazie. 331:13-21
A series of new indazol-3-ol derivatives was synthesized. Some of these compounds exhibit interesting anti-inflammatory activities in various models of inflammation. 5-Methoxy-1-[quinoline-2-yl-methoxy)-benzyl]-1H-indazol-3-ol (27) strongly inhibits
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91a2c57b3afa8f76182176743d27cf32
https://doi.org/10.1002/(sici)1521-4184(199801)331:1<13::aid-ardp13>3.0.co
https://doi.org/10.1002/(sici)1521-4184(199801)331:1<13::aid-ardp13>3.0.co
Autor:
Helmut A. Tritthart, U. Stark, Decrinis M, Degenhard Marx, Gerhard Stark, Ingrid Schwarzl, Hildegard Poppe
Publikováno v:
Cardiovascular Drugs and Therapy. 10:531-538
In isolated spontaneously beating guinea pig hearts, the effects of AWD 23-111 (N-(dicyclohexylcarbamoylmethyl)-N-(3-diethylamino-propyl)-4-nit robenzamid -hydrochloride), a new synthetic class III antiarrhythmic agent with sodium antagonistic proper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9742bec4072ba2e0d43bf1f3cb0444
https://doi.org/10.1007/bf00050993
https://doi.org/10.1007/bf00050993
Autor:
Degenhard Marx, U. Stark, Ingrid Schwarzl, Günther Weber, Decrinis M, Hildegard Poppe, Gerhard Stark, Helmut A. Tritthart
Publikováno v:
Journal of Cardiovascular Pharmacology. 27:125-131
Detajmium (4--3'-diethylamino-2'-hydroxypropyl--ajmalin) is an Na(+)-channel-blocking drug with an extremely long recovery from use-dependent sodium channel block. The aim of the present study was to investigate the rate-dependent effects of detajmiu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baba13d03ecbccfab1550e3ec19fbc41
https://doi.org/10.1097/00005344-199601000-00020
https://doi.org/10.1097/00005344-199601000-00020